tibolone has been researched along with Dyspareunia in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Balduzzi, S; Basevi, V; Bassi, C; D'Amico, R; Formoso, G; Maestri, E; Magrini, N; Maltoni, S; Marata, AM; Perrone, E; Wilkinson, J | 1 |
Basson, R; Brotto, L; van Lankveld, J; Wierman, ME | 1 |
Balduzzi, S; Basevi, V; Bassi, C; D'Amico, R; Formoso, G; Maestri, E; Magrini, N; Maltoni, S; Marata, AM; Perrone, E | 1 |
Luzuy, F; Martin-Du Pan, RC | 1 |
3 review(s) available for tibolone and Dyspareunia
Article | Year |
---|---|
Short-term and long-term effects of tibolone in postmenopausal women.
Topics: Aged; Breast Neoplasms; Dyspareunia; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Middle Aged; Neoplasm Recurrence, Local; Norpregnenes; Postmenopause; Randomized Controlled Trials as Topic; Stroke; Sweating; Uterine Hemorrhage | 2016 |
Short and long term effects of tibolone in postmenopausal women.
Topics: Aged; Breast Neoplasms; Dyspareunia; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Middle Aged; Neoplasm Recurrence, Local; Norpregnenes; Postmenopause; Stroke; Sweating; Uterine Hemorrhage | 2012 |
[What's new in hormone replacement therapy for postmenopausal women? I. Advantages of hormone replacement therapy (HRT)].
Topics: Aged; Alzheimer Disease; Cardiovascular Diseases; Cholesterol, HDL; Depression; Dyspareunia; Estrogen Replacement Therapy; Female; Humans; Male; Megestrol; Middle Aged; Norpregnenes; Osteoporosis; Postmenopause; Progesterone Congeners | 2000 |
1 other study(ies) available for tibolone and Dyspareunia
Article | Year |
---|---|
Summary of the recommendations on sexual dysfunctions in women.
Topics: Adjuvants, Immunologic; Dehydroepiandrosterone; Diagnostic and Statistical Manual of Mental Disorders; Dyspareunia; Estrogen Receptor Modulators; Estrogens; Female; Guidelines as Topic; Humans; Libido; Norpregnenes; Physical Examination; Psychology; Severity of Illness Index; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological; Vaginismus | 2010 |